Outcomes of a new study shows that obese men with high insulin levels are more likely die from prostate cancer if they are diagnosed with the disease.

The findings have been published online earlier and they are expected to be published in the November issue of The Lancet Oncology as well.

The lead author of the study, Dr. Michael Pollak , who is a professor of oncology at McGill University in Montreal, Quebec, Canada, said: “ I am not a sensationalist, but the effects of obesity and insulin are so big that if you have to choose between being thin and a low insulin level or access to the best chemotherapy, you may be more likely to survive without chemotherapy.”Some other reports have already suggested that overweight patients with prostrate cancer are at a higher risk of death than the patients with normal weight. However, weight is not related to develop a malignancy in actual.

Pollak added, “Our study suggests that obesity has a vital influence on prostate cancer outcome, but the question rises, why do the outcomes become worse because of obesity.”

In the study, Pollak and his team looked at data on more than 2,500 men who were followed for 24 years as a part of the Physicians’ Health Study.